<?xml version="1.0" ?>
<document id="5c3f5dde0537e3072d046990501a4e71471d9ddc">
  <chunk id="5c3f5dde0537e3072d046990501a4e71471d9ddc.c0" text="DC-SIGN gene promoter variants and IVIG treatment response in Kawasaki disease">
    <entity charOffset="62-78" id="5c3f5dde0537e3072d046990501a4e71471d9ddc.c0.e0" ontology_id="DOID_13378" text="Kawasaki disease" type="disease"/>
    <entity charOffset="71-78" id="5c3f5dde0537e3072d046990501a4e71471d9ddc.c0.e1" ontology_id="DOID_4" text="disease" type="disease"/>
  </chunk>
  <chunk id="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1" text="Background: Genetic variants in the inhibiting FcγRIIB mediate anti-inflammatory responses and influence IVIG refractoriness (IVIG-R). However, these variants are rare in Asian and Hispanic populations so other genes in the pathway could be potentially involved. IVIG is ineffective in mice lacking SIGN-R1, a related molecule to human DC-SIGN. Further, DC-SIGN is a known receptor for sialylated Fc, the component responsible for the anti-inflammatory action of IVIG. Thus, we hypothesized that DC-SIGN would also be involved in the pathway of IVIG response in Kawasaki Disease (KD) patients. Findings: A case-control approach was performed to examine the differential distribution of five single nucleotide polymorphisms (SNPs) in DC-SIGN promoter with IVIG-R among White (158 vs. 62), Asian (64 vs. 12) and Hispanic (55 vs. 20) KD patients. Distinct differences in allele frequency distributions of several variants in the DC-SIGN promoter were observed in the three ethnic groups. Further, Asians with the major allele &quot;A&quot; in rs2287886 were more likely (OR = 1.76, p = 0.04) to be IVIG non-responder, but this allele is a minor allele in other two ethnic groups, where the association was not apparent. Conclusions: DC-SIGN can potentially complement the role of FcγRIIB in the anti-inflammatory cascade involved in the IVIG response mechanism.">
    <entity charOffset="224-231" id="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e0" ontology_id="CHEBI_34922" text="pathway" type="chemical"/>
    <entity charOffset="318-326" id="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e1" ontology_id="CHEBI_25367" text="molecule" type="chemical"/>
    <entity charOffset="453-459" id="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e2" ontology_id="CHEBI_5133" text="action" type="chemical"/>
    <entity charOffset="534-541" id="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e3" ontology_id="CHEBI_34922" text="pathway" type="chemical"/>
    <entity charOffset="562-578" id="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e4" ontology_id="DOID_13378" text="Kawasaki Disease" type="disease"/>
    <entity charOffset="571-578" id="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e5" ontology_id="DOID_4" text="Disease" type="disease"/>
    <entity charOffset="698-708" id="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e6" ontology_id="CHEBI_36976" text="nucleotide" type="chemical"/>
    <entity charOffset="1228-1231" id="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e7" ontology_id="CHEBI_29320" text="can" type="chemical"/>
    <entity charOffset="1259-1263" id="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e8" ontology_id="CHEBI_50906" text="role" type="chemical"/>
    <pair e1="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e0" e2="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e4" id="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.p0" relation="true"/>
    <pair e1="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e0" e2="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e5" id="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.p1" relation="true"/>
    <pair e1="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e1" e2="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e4" id="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.p2" relation="true"/>
    <pair e1="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e1" e2="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e5" id="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.p3" relation="true"/>
    <pair e1="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e2" e2="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e4" id="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.p4" relation="true"/>
    <pair e1="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e2" e2="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e5" id="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.p5" relation="true"/>
    <pair e1="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e3" e2="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e4" id="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.p6" relation="true"/>
    <pair e1="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e3" e2="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e5" id="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.p7" relation="true"/>
    <pair e1="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e4" e2="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e6" id="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.p8" relation="true"/>
    <pair e1="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e4" e2="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e7" id="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.p9" relation="true"/>
    <pair e1="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e4" e2="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e8" id="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.p10" relation="true"/>
    <pair e1="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e5" e2="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e6" id="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.p11" relation="true"/>
    <pair e1="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e5" e2="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e7" id="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.p12" relation="true"/>
    <pair e1="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e5" e2="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.e8" id="5c3f5dde0537e3072d046990501a4e71471d9ddc.c1.p13" relation="true"/>
  </chunk>
</document>
